A study revealed a nearly 25% rate of all-cause mortality among patients on maintenance dialysis who contract COVID-19.
Dialysis use among older Veterans Affairs (VA) patients with incident kidney failure varied from 25.0% to 81.4% across 108 VA facilities, a study found.
The approval was based on data from the open-label, active-controlled phase 3 ANDROMEDA study.
Study results show that mortality among hemodialysis patients declined from 2006 to 2015 compared with the general Swedish population.
Elevated levels of 3 immune system biomarkers are associated with an increased risks for kidney failure requiring renal replacement therapy and death, a study found.
Sparsentan is an investigational small molecule candidate designed to selectively block the receptors of endothelin type A and angiotensin II type I, which are associated with kidney disease progression.
In a trial of patients with primary membranous nephropathy, corticosteroid-cyclophosphamide induced significantly more and faster remission of nephrotic syndrome than tacrolimus-rituximab.
Older patients have lower mobile health proficiency, as do those with Hispanic/Latinx ethnicity, less than college education
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
A Swedish study of patients with moderate to severe chronic kidney disease found that women were less likely than men to experience disease progression and to die from any cause or cardiovascular causes.